Results 251 to 260 of about 35,674 (297)

Commentary on Comstock et al.: Here we go again—Kratom and the failure to learn from the opioid crisis

Addiction, EarlyView.
Andrew Kolodny
wiley   +1 more source

Prevalence and Burden of Fatigue Across Disorders of Gut–Brain Interaction: Results From the Rome Foundation Global Epidemiology Study

Alimentary Pharmacology &Therapeutics, EarlyView.
Fatigue is common and burdensome in disorders of gut‐brain interaction and increases with diagnostic overlap. In this global population‐based study, fatigue was associated with female sex, age, BMI, sleep disturbance, higher anxiety and depression scores, greater somatic symptom burden, lower psychological well‐being, antidepressant use, and greater ...
Fleur Veldman, Francesco Innocenti, Imran Aziz, Asma Fikree, Shrikant I. Bangdiwala, Olafur Palsson, Ami D. Sperber, Daniel Keszthelyi   +7 more
wiley   +1 more source

Perceived impacts of medications for opioid use disorder implementation on mental health services and substance use counseling in carceral settings: qualitative findings from 13 Massachusetts jails. [PDF]

Addict Sci Clin Pract
Pivovarova E, Friedmann PD, Ferguson W, Bovell Ammon BJ, Stopka TJ, Evans EA.   +5 more
europepmc   +1 more source

Increasing Initiation of Medications for Opioid Use Disorder Through Recovery Coaches: The Role of Implementation Setting. [PDF]

J Addict Med
Knudsen HK, Fallin-Bennett A, Fanucchi L, Lofwall MR, McGladrey M, Oser CB, Biggers G, Ross A, Chadwell J, Walsh SL.   +9 more
europepmc   +1 more source

Effects of the Communities That HEAL intervention on initiation, retention, and linkage to medications for opioid use disorder (MOUD): A cluster randomized wait-list controlled trial. [PDF]

Drug Alcohol Depend
Brown JL, Larochelle MR, Fanucchi LC, Calvert DC, Campbell ANC, Chandler RK, Feaster DJ, Glasgow LM, Gibson EB, Holloway J, Lofwall MR, Mack A, Mack N, Nunes EV, Talbert JC, Tan S, Vandergrift N, Villani J, Asman K, Babakhanlou-Chase H, Bagley SM, Battaglia TA, Blevins D, Bridden C, Cheng DM, Christopher M, Cogan LW, Cunningham CO, Eggleston B, Fareed N, Fernandez S, Freedman DA, Freiermuth CE, Freisthler B, Gilbert L, Hammerslag L, Harris D, Hunt T, Hussain S, Huynh P, Jackson RD, Kauffman EB, Knott C, Knudsen HK, Lefebvre RC, Levin FR, Massatti R, McAlearney AS, Morgan JR, Lopez RM, Lounsbury DW, Newman L, Nickels K, Oga EA, Oller DA, Parran TV, Quinn M, Ramsey KS, Rapkin BD, Salsberry P, Stein M, Taylor JL, Teater J, Walters ST, Zarkin GA, El-Bassel N, Winhusen TJ, Samet JH, Walsh SL.   +68 more
europepmc   +1 more source

The role of micro-, meso-, and macro-level stigma on the uptake of medications for opioid use disorder (MOUD) among women in the criminal legal system. [PDF]

BMC Womens Health
Quadri OH, Skogseth E, Brant K, Jones AA.   +3 more
europepmc   +1 more source

Barriers to Universal Availability of Medications for Opioid Use Disorder in US Jails.

JAMA Netw Open
Flanagan Balawajder E, Ducharme L, Taylor BG, Lamuda PA, Kolak M, Friedmann PD, Pollack HA, Schneider JA.   +7 more
europepmc   +1 more source

Underuse of Lifesaving Medications for Opioid Use Disorder in US Jails

JAMA Network Open
openaire   +2 more sources

Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA

Neurotherapeutics, 2020
Despite high mortality rates due to opioid overdose and excessive alcohol consumption, medications for the treatment of alcohol and opioid use disorder have not been widely used in the USA.
Amanda J Abraham, Christina M Andrews, Samantha J Harris   +2 more
exaly   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Medications for Opioid Use Disorder During Incarceration

Journal of Addictions Nursing, 2022
Abstract The opioid epidemic has had a devastating impact on incarcerated individuals, with significantly higher rates of opioid use disorder (OUD) and risk of opioid overdose than the general public. Medications for OUD (MOUDs) are currently used with an interdisciplinary approach with good outcomes, but MOUD-approved medications are grossly
Erin R. McDermott-Winger, Christine L. Latham   +1 more
openaire   +2 more sources